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Abstract
Glutamatergic synapse maturation is critically dependent upon activation of NMDA-type glutamate receptors (NMDARs);
however, the contributions of NR3A subunit-containing NMDARs to this process have only begun to be considered. Here we
characterized the expression of NR3A in the developing mouse forebrain and examined the consequences of NR3A deletion
on excitatory synapse maturation. We found that NR3A is expressed in many subcellular compartments, and during early
development, NR3A subunits are particularly concentrated in the postsynaptic density (PSD). NR3A levels dramatically
decline with age and are no longer enriched at PSDs in juveniles and adults. Genetic deletion of NR3A accelerates
glutamatergic synaptic transmission, as measured by AMPAR-mediated postsynaptic currents recorded in hippocampal
CA1. Consistent with the functional observations, we observed that the deletion of NR3A accelerated the expression of the
glutamate receptor subunits NR1, NR2A, and GluR1 in the PSD in postnatal day (P) 8 mice. These data support the idea that
glutamate receptors concentrate at synapses earlier in NR3A-knockout (NR3A-KO) mice. The precocious maturation of both
AMPAR function and glutamate receptor expression are transient in NR3A-KO mice, as AMPAR currents and glutamate
receptor protein levels are similar in NR3A-KO and wildtype mice by P16, an age when endogenous NR3A levels are
normally declining. Taken together, our data support a model whereby NR3A negatively regulates the developmental
stabilization of glutamate receptors involved in excitatory neurotransmission, synaptogenesis, and spine growth.
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Introduction
In early postnatal development, the formation and maturation
of excitatory synapses play critical roles in the proper wiring of
neuronal networks required for learning and memory. The
balance between synapse stabilization and elimination is highly
sensitive to changes in the complement of synaptic proteins. The
subunit composition of NMDA- and AMPA-type glutamate
receptors (NMDARs and AMPARs) is particularly important for
defining ionotropic glutamate receptor-mediated synaptic trans-
mission. Synaptic activity and sensory experience modify synaptic
function, in part by promoting the transition between ‘immature’
and ‘mature’ forms of NMDARs (from predominantly NR2B- to
NR2A-containing) in the postsynaptic density (PSD) and by the
synaptic incorporation of AMPARs. These changes regulate the
stabilization of the PSD, the subsequent decline in functional
plasticity of the synapse, and the spine growth associated with
synapse maturation [1].
NMDAR activation is crucial for synaptic strengthening and
weakening [1,2], processes that are pronounced during early life
[3,4] and instructive for proper brain development. NMDARs
form through the assembly of NR2 (A–D) and NR3 (A–B) subunits
with an obligatory NR1 dimer [5], also referred to as GluN1-
GluN3B subunits. Most research in the mouse forebrain has
concentrated on the canonical subtypes, NR2A and NR2B.
Recent reports, however, have shown that the inclusion of NR3
subunits with NR1 and NR2 subunits alters NMDAR functions by
reducing currents, lowering calcium permeability, and reducing
block by magnesium [6,7,8,9,10,11,12,13,14]. Thus, unlike most
NMDAR subunits, NR3A acts in a novel, dominant-negative
manner to limit receptor function and the ability of synapses to
strengthen [8,14]. Interestingly, however, when expressed with
NR1 alone, in the absence of NR2 subunits, NR3-NMDARs form
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a glycine-sensitive cation channel [15,16,17]; although these
NR1/NR3 channels appear to be expressed in myelin rather
than neurons [18].
Maximal NR3A expression coincides with a period during
which many synapses are being formed, stabilized, or eliminated
[19]. Like the NR2A and NR2B subunits, NR3A expression is
developmentally regulated. However, its profile is unique, being
highly expressed in early postnatal life and downregulating sharply
into adulthood in humans, monkeys, and rodents [20]. This
suggests that the regulation of NR3A expression is a common
feature of brain development and that the function of NR3A is
similar between mammalian species. Immunogold electron
microscopy experiments in wildtype (WT) mice have shown that
NR3A is normally absent from large synapses [14], suggesting that
the presence of NR3A-containing NMDARs may serve to limit
synapse growth and maturation. In support of this idea, loss- and
gain-of-function studies in NR3A mutant mice have shown that
spine number and synapse size are increased in the absence of
NR3A [8] and reduced with the overexpression of NR3A [14].
Importantly, NR3A expression also appears to limit the expression
of long-term potentiation, a form of synaptic plasticity, and
memory consolidation [14].
Given the importance of NR3A for synaptic function and
memory formation, here we sought to further investigate how
NR3A regulates the transition from immature to mature synapses.
We aimed to define the subcellular localization of NR3A-
containing receptors at peak expression levels (,P8 in mouse
forebrain), and to establish the consequences of deleting NR3A on
PSD proteins. We found that NR3A is synaptically targeted during
early development, and this preferential expression at the PSD is
lost with age. The genetic deletion of NR3A causes NMDARs and
AMPARs to concentrate prematurely at synapses, and results in
enhanced AMPAR currents in CA1 hippocampal pyramidal
neurons. However, these measures in NR3A-KO mice return to
WT control levels at an age when endogenous NR3A expression is
normally declining (,P16 in mice). Our results support a model by
which NR3A expression inhibits glutamatergic synaptic transmis-
sion, thus providing a molecular brake to limit the premature
development of forebrain synapse size, strength, and the ability to
form lasting long-term memories during early development [14].
Materials and Methods
Ethics statement
Animal use in this study was approved by the Institutional
Animal Care and Use Committee of the University of North
Carolina at Chapel Hill (protocol #10-115.0) in accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
Homozygous WT and NR3A-KO offspring were selected from
a mixed heterozygote colony and then maintained on a C57BL/6J
background as separate homozygous breeding colonies. The
generation and genotyping procedure of NR3A-KO mice have
been previously described [8]. All mice were maintained on a
12:12 light/dark cycle and sacrificed according to approved
protocol guidelines.
Tissue collection
Brains were removed from mice at postnatal (P) days 8, 16, and
.40 (range from P40-55). Forebrain tissue was rapidly dissected,
frozen on dry ice, and stored at 280uC until use.
Subcellular fractionation
One to three forebrains from each genotype, NR3A-KO or
WT, were pooled for each fraction (n = 5–10 fractions/antibody
for each age). Biochemical fractions were prepared as described
[14], ending with the collection of the first detergent-extracted
PSD fraction. Briefly, tissues were dounce-homogenized in
HEPES-buffered sucrose (4 mM HEPES, 0.32 M sucrose,
pH 7.4) and centrifuged (10006 g for 10 min) to yield the
postnuclear supernatant (PNS) fraction. Synaptosomal pellets were
lysed in hypo-osmotic solution, layered on a discontinuous
gradient consisting of 0.32, 0.8, 1.0, and 1.2 M sucrose in 4 mM
HEPES, pH 7.4, and subjected to density centrifugation
(150,0006 g for 2 h). The synaptic plasma membrane (SPM)
fraction was collected from the 1.0/1.2 M sucrose interface,
resuspended in 0.5% Triton X-100-containing buffer, and
centrifuged to obtain the postsynaptic density (PSD) fraction.
Complete protease inhibitors (Roche Applied Science, Germany),
and phosphatase inhibitor mixtures 1 and 2 (Sigma-Aldrich, St
Louis, MO) were added to all buffers. Procedures were performed
on ice and/or in a cold room and fractions were stored at 280uC.
Protein concentrations were determined by BCA Assay (Pierce
Chemical, Rockford, IL). The following fractions were collected in
this study: PNS, whole homogenate, postnuclear supernatant;
CYT, cytosol; LM, light membranes; P2, crude synaptosomes; P3,
lysed synaptic membranes; SPM, purified synaptic plasma
membranes; TSF, Triton-soluble fraction; PSD, postsynaptic
densities.
Quantitative immunoblotting
Increasing amounts (1–15 mg) of total protein from each fraction
were loaded in wells of 4–12% or 8% tris-glycine Novex gels
(Invitrogen), resolved by SDS-PAGE, and transferred to nitrocel-
lulose membranes. Blotting (Bio-Rad) and Odyssey system
imaging and quantification (LI-COR) were carried out following
manufacturers’ protocols. The following antibodies were used at
optimized concentrations: goat anti-NR1 (sc-1467, 0.01 mg/ml,
Santa Cruz Biotechnology), rabbit anti-NR3A (07-356, 2 mg/ml,
Millipore), goat anti-NR2B (sc-1469, 0.02 mg/ml, Santa Cruz
Biotechnology), rabbit anti-NR2A (AB1555 and 04-901, 0.1 mg/
ml, Millipore), rabbit anti-GluR1 (AB1504, 0.05 mg/ml, Milli-
pore), mouse anti-PSD-95 (MAB1596, 1 mg/ml, Chemicon),
mouse anti-synaptophysin (Syp, S-5768, 0.5 mg/ml, Sigma-
Aldrich), mouse anti-b-tubulin (MAB 3408, 10 mg/ml, Chemicon),
Alexa Fluor 680-labeled donkey anti-goat IgG (#A21084,
Invitrogen), Alexa Fluor 680-labeled goat anti-mouse IgG
(#A21058, Invitrogen), and IRDye 800-labeled donkey anti-
rabbit IgG (#611-732-127, Rockland Immunochemicals). All
samples were run multiple times.
Hippocampal slice preparation
Mice were anesthetized with sodium pentobarbital and eutha-
nized upon disappearance of corneal reflexes. Brains were rapidly
removed and immersed in ice-cold dissection buffer (composition
in mM: NaCl, 87; KCl, 2.5; NaH2PO4, 1.25; NaHCO3, 26;
sucrose, 75; D-(+)-glucose, 10; ascorbic acid, 1.3; MgCl2, 7; and
CaCl2, 0.5) and bubbled with 95% O2 and 5% CO2. The
hippocampus was dissected and then 350 mm coronal slices were
prepared using a vibrating microtome (VT1200S; Leica, Ban-
nockburn, IL). Slices were allowed to recover for 20 min in a 35uC
submersion chamber filled with oxygenated artificial cerebrospinal
fluid (ACSF) (composition in mM: NaCl, 124; KCl, 3;
Na2PO4,1.25; NaHCO3, 26; MgCl2, 1; CaCl2, 2; D-(+)-glucose,
20) and then kept at room temperature for at least 40 min until
use.
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Figure 1. Subcellular fractionation of presynaptic and postsynaptic proteins in forebrain neurons. (A) Schematic illustration of the
enrichment process, highlighting the key fractions examined in this study (see Methods for details). The PNS fraction obtained from the homogenate
is subjected to a series of centrifugation steps to isolate pre- and postsynaptic plasma membranes (SPM), including layering on a sucrose gradient,
and finally extracting with detergent to obtain the postsynaptic densities (PSD). (B) Representative immunoblots show NR1, PSD-95, and
synaptophysin (Syp) expression in fractions from P16 mouse forebrain, with 5 or 10 mg total protein loaded in each lane as indicated. (C)
Quantification of fraction fold-enrichment made with sample values normalized to PNS fractions. Error bars represent SEM. PNS, postnuclear
supernatant; CYT, cytosol; LM, light membranes; P2, crude synaptosomes; P3, lysed synaptic membranes; SPM, purified synaptic plasma membranes;
TSF, Triton-soluble fraction; PSD, postsynaptic densities.
doi:10.1371/journal.pone.0042327.g001
Role of NR3A in Synapse Development
PLoS ONE | www.plosone.org 3 August 2012 | Volume 7 | Issue 8 | e42327
Voltage-clamp recordings
Patch pipettes were pulled from thick-walled borosilicate glass.
Open tip resistances were 2–7 MV when pipettes were filled with
an internal solution containing (in mM): cesium hydroxide, 107; D-
gluconic acid, 107; TEA-chloride, 5; NaCl, 3.7; HEPES, 20;
sodium guanosine triphosphate, 0.3; magnesium adenosine
triphosphate, 4; EGTA, 0.2; BAPTA, 10; and QX-314 chloride,
5 (Alomone Labs), with pH adjusted to 7.2 and osmolarity
adjusted to 300 mOsm by the addition of sucrose. Hippocampal
CA1 pyramidal cells were voltage-clamped in the whole-cell
configuration using a patch-clamp amplifier (Multiclamp 700A;
Molecular Devices, Sunnyvale, CA), and data were acquired and
analyzed using pCLAMP 9.2 software (Molecular Devices).
Changes in series resistance were monitored throughout the
experiment by giving a test pulse and measuring the amplitude of
the capacitive current. Only cells with series resistance ,18 MV
were included for analysis. Input resistance was monitored
throughout the experiment by measuring the amplitude of the
steady-state current, filtered at 2 kHz, evoked from a test pulse.
Only cells with ,30% change in Rinput and Rseries were included
for analysis. EPSCs were evoked from a stimulating electrode (two-
conductor cluster electrodes with 75 mm tip separation; FHC,
Bowdoin, ME) by stimulation (200 ms every 15 sec) of the stratum
radiatum. For AMPA input-output curves, EPSCs were recorded
at 280 mV and two trials at the same stimulus intensity were
averaged to produce a measurement of AMPAR current at a given
stimulus intensity. AMPAR currents were pharmacologically
isolated by modifying the standard ACSF to contain picrotoxin
(50 mM, Sigma-Aldrich) and D,L-APV (10 mM, Ascent Scientific),
and this bath solution was perfused at 2 ml/min at 30uC. A
minimum of three animals were used per experimental group.
Data Analysis
Calculations of signal intensity per microgram protein were
determined from multiple wells on each gel for each target antigen
and then averaged across multiple gels. Fraction means per
genotype were either presented as immunoreactive (IR) units/mg
protein or normalized to mean control values and expressed as %
of control or % of maximum. Error bars represent mean 6 SEM.
Statistical evaluations were performed using either two-tailed
student’s t-tests or one-way analyses of variance (ANOVAs) (for
multiple group comparisons), followed by between-group com-
parisons with Tukey-Kramer tests (Graphpad Instat, San Diego,
CA). Significance was placed at p,0.05.
Results
Biochemical enrichment of synaptic proteins by
subcellular fractionation
To examine the subcellular localization of glutamate receptor
subunit proteins in forebrain neurons, we performed immunoblot
analysis on various fractions extracted from WT and NR3A-KO
mice (Figure 1a), including selectively enriched homogenates for
synaptic complexes (SPM) and postsynaptic densities (PSD). To
demonstrate the quality of fractions prepared from homogenates
derived from centrifugal removal of nuclei (PNS, postnuclear
supernatant), the fractions were probed by immunoblot analysis of
presynaptic and postsynaptic markers. The fidelity of this
biochemical fractionation was validated by the near absence of
membrane proteins (e.g., glutamate receptor subunit, NR1) in the
cytosolic (CYT) fraction; negligible expression of the presynaptic
protein, synaptophysin (Syp), in the PSD; absence of the
postsynaptic density protein, PSD-95, from the Triton-soluble
fraction (TSF); and progressive enrichment of NR1 and PSD-95
from the initial homogenate (PNS) to the PSD (Figure 1b, c).
Because the PSD fractions are highly enriched, a two-fold
reduction in protein loading over the previous fractions was used
to avoid saturation of the blotted bands.
NR3A is concentrated in neonatal PSDs and undergoes a
developmental decline
To determine the subcellular localization of NR3A-containing
receptors over mouse forebrain development, we first determined
to which biochemical compartments NR3A is targeted at its age
(P8) of peak expression [21]. Western blots probed with an anti-
NR3A antibody revealed that at P8, NR3A is expressed
predominantly in membranous fractions, including the light
membranes (LM) fraction that contains intracellular organelles
(e.g., microsomes, endosomes, Golgi, endoplasmic reticulum), the
synaptic junction (SPM) fraction containing pre- and postsynaptic
proteins, and the PSD fraction (Figure 2a). These data are
consistent with a previous report using juvenile rats [21]. The
strong presence of NR3A in the different membrane fractions
suggests that these receptors are mobile in the plasma membrane,
as has been suggested of NMDARs in general [22].
Because NMDAR subunit composition and localization deter-
mines synaptic functions, we further probed how the subcellular
expression of NR3A changes with age. Our study focused on the
PNS, SPM, and PSD fractions taken from P8 (neonatal), P16
(juvenile), and age .P40 (young adult) mice. We found that NR3A
levels decrease 50–70% from P8 through adulthood in all fractions
(Figure 2b, PNS, F(2,17) = 17.988, p = 0.0001; SPM, F(2,19) = 5.397,
p = 0.0153; PSD, F(2,19) = 23.612, p,0.0001). The developmental
profile we observed for NR3A is similar to that reported previously
[20]. We found that NR3A is particularly enriched within the PSD
at P8, when NR3A levels are highest [8,21] (Figure 2c, P8,
F(2,23) = 8.973, p = 0.0015). However, NR3A levels in PSD fractions
decrease significantly at juvenile and young adult ages (Figure 2b,
PSD, F(2,19) = 23.612, p,0.0001; P16% of maximum = 70.868.4,
p,0.05; .P40% of maximum = 32.963.1, p,0.0001) and PSD
enrichment is lost after P8 (Figure 2c, P16, F(2,16) = 2.682,
p = 0.1033; .P40, F(2,16) = 3.034, p = 0.080). These data indicate
that not only do NR3A levels decline dramatically during
development, but also the privileged access of NR3A-containing
NMDARs to the PSD is lost with age.
Glutamate receptor proteins are enriched in PSD
fractions
NR3A is thought to suppress NMDAR activity during early life
to limit synaptic strengthening and stabilization [14]. As such, we
hypothesized that manipulations of NR3A would alter the synaptic
recruitment of glutamate receptor subunits involved in the
maturation of excitatory synapses. Consistent with this hypothesis,
we recently showed that the synaptic concentration of NR1 is
significantly increased in neonatal NR3A knockout mice [14]. We
reasoned that if NR3A negatively regulates NR1 localization and
numbers at synaptic junctions, other glutamate receptor subunits
might be similarly affected. To test how NR3A loss affects
ionotropic receptor subunit expression, we first had to establish the
normal developmental expression of selected subunits in our
system. We chose to examine expression of NR1, NR2A, NR2B,
and GluR1 subunits due to their high expression levels in
developing rodent forebrain and their involvement in synaptic
plasticity and maturation (mRNA: [23,24,25,26,27,28,29]; pro-
tein: [29,30,31,32,33,34,35,36,37,38,39,48]).
We delineated the developmental expression profiles of these
NMDAR and AMPAR subunits present in forebrain fractions
Role of NR3A in Synapse Development
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from P8, P16, and young adult mice. This not only provided a
baseline to which we could directly compare the NR3A data, but
also confirmed the reproducibility of our biochemical fractionation
protocol. Importantly, while the developmental profiles we observe
for NR1, NR2A, NR2B, and GluR1 are generally consistent with
previous reports, our analyses provide insights into the localization
of these glutamate receptor subunits in different biochemical
fractions across several ages (Figure 3).
Because NR1 is required for all functional NMDARs
[40,41,42], we confirmed that NR1 levels are enriched from the
initial PNS fraction to the PSD [8,14,21,34,37,43] at each age and
are similar across development [25,34,35,36,37,39,44] within each
fraction (Figure 3a: NR1 comparison by ages: P8,
F(2,23) = 74.691, p,0.0001; P16, F(2,17) = 44.507, p,0.0001;
.P40, F(2,16) = 29.234, p,0.0001; NR1 comparison by fractions:
PNS, F(2,18) = 1.636, p = 0.2258; SPM, F(2,19) = 1.404, p = 0.2727;
PSD, F(2,19) = 0.3277, p = 0.7250.).
Similarly, NR2B showed abundant expression during early life
and minimal change with age [25,33,36,37,44,45] within each
fraction, being highly enriched in the PSD compared to PNS
homogenate fractions [21,34,37,43,46] (Figure 3c: NR2B com-
parison by ages: P8, F(2,23) = 32.582, p,0.0001; P16,
F(2,17) = 77.483, p,0.0001; .P40, F(2,17) = 31.964, p,0.0001;
NR2B comparison by fractions: PNS, F(2,19) = 2.304, p = 0.1302;
SPM, F(2,19) = 2.617, p = 0.1021; PSD, F(2,19) = 1.046, p = 0.3730).
In contrast, we found that NR2A levels are very low during
early development and increase dramatically after the first week of
life, as expected [23,25,31,33,34,35,36,37,39,44,45]. This subunit
was also concentrated in the PSD [21,37,43,46] (Figure 3b:
NR2A comparison by ages: P8, F(2,22) = 11.725, p = 0.0004; P16,
F(2,16) = 14.377, p = 0.0004; .P40, F(2,17) = 39.610, p,0.0001;
NR2A comparison by fractions: PNS, F(2,18) = 12.549,
p = 0.0005; SPM, F(2,19) = 53.233, p,0.0001; PSD,
F(2,18) = 28.548, p,0.0001). These increases in protein levels
indicate that NR2A is significantly regulated across developmental
ages, consistent with previous observations
[29,33,34,36,37,44,45,47,48]. The developmental shift in NR2A
and NR2B subunit composition (compare Figure 3b to 3c) has
been well-characterized, as it alters the ability of synapses to
strengthen and weaken in response to activity [2]. Although we
might have expected to see more enrichment of NR2A at PSDs
when compared to NR2B, especially at adult stages (P8: 5- vs. 12-
fold enrichment, respectively; P16: 5- vs. 9-fold enrichment; .P40:
8- vs. 12-fold enrichment), the high concentration of these subunits
at the postsynaptic density is consistent with previous reports
[34,39,46], and suggests that receptors containing NR2A and
NR2B are preferentially targeted to the PSD.
In line with other studies [32,38,44,49,50,51], we found that
GluR1, like NR2A, also exhibits expression onset just after the first
postnatal week, increases dramatically into adulthood, and is
Figure 2. Developmental reduction in NR3A levels and PSD targeting. (A) Representative immunoblots of biochemical fractionation from
P8, P16, and .P40 forebrain. (B) NR3A protein levels in the PNS, SPM, and PSD fractions from mice at P8, P16, and .P40. NR3A levels decrease during
development in all fractions. Data are averaged means of immunoreactive (IR) values relative to protein loads (mg). (C) Averaged data normalized to
initial homogenate values (total receptor protein) to highlight the shift in NR3A expression away from the PSD fraction. Error bars represent SEM. *
p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0042327.g002
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enriched in the PSD at all ages (Figure 3d: GluR1 comparison by
ages: P8, F(2,21) = 30.729, p,0.0001; P16, F(2,15) = 6.454,
p = 0.0113; .P40, F(2,17) = 12.991, p = 0.0005; GluR1 comparison
by fractions: PNS, F(2,17) = 57.918, p,0.0001; SPM,
F(2,17) = 13.702, p = 0.0004; PSD, F(2,19) = 40.306, p,0.0001).
The preferential activity-dependent recruitment of GluR1-con-
taining AMPARs is thought to result from LTP during the early
phases of synapse maturation [52,53,54,55].
Synapse maturation markers, NR1, NR2A and GluR1,
concentrate earlier in PSDs of NR3A-KO mice
To examine the effects of genetic deletion of NR3A on the
composition of glutamate receptor subunits, we measured changes in
protein levels of synapse maturation markers in NR3A-KO and WT
mice over development. We found that both NMDAR and AMPAR
subunit abundance in PSD fractions are significantly increased in P8
knockouts. Immunoblot analysis of synaptic membranes revealed
that, like NR1 (Figure 4a, NR1% of control = 138.6613.4, n = 8–9,
p = 0.033; data re-plotted from [14] for comparative purposes), PSD
levels of synapse maturation markers, NR2A and GluR1, are also
enhanced in NR3A-KO compared to WT mice at age P8
(Figure 4b, NR2A% of control = 150.4616.3, n = 7–8, p = 0.047;
Figure 4c; GluR1% of control = 142.4612.9, n = 8, p = 0.046). Both
NR2A and GluR1 WT expression levels are very low at this age
(Figure 3b, NR2A% of maximum = 12.6962.02; Figure 3d,
GluR1 % of maximum = 13.4961.95), and their increased levels in
mutant PSDs indicate that the loss of NR3A promotes the early
concentrations at synapses of both NR2A-NMDARs and GluR1-
AMPARs. No differences were observed in total receptor protein
fractions (PNS, data not shown). These data also indicate that NR3A
limits synaptic expression of AMPARs as well as NMDARs. The
increase of NR2A in the NR3A-KO PSD fraction may point to a
critical role of NR3A in preventing NR2A from being targeted to the
PSD.
Because the NR2B subunit is also highly expressed in immature
forebrains during the early postnatal period, we examined whether
any changes occurred for NR2B subunit expression in the NR3A-
KO forebrain. However, in contrast to the pronounced upregula-
tion of NR1, NR2A, and GluR1, we observed no discernible
changes in NR2B expression levels (Figure 4d,
NR2B% of control = 100.669.3, n = 8–9, p = 0.972).
Figure 3. Glutamate receptor subunits NR1, NR2A, NR2B, and GluR1 are highly enriched in PSDs of postnatal mice. Relative protein
levels of (A) NR1, (B) NR2A, (C) NR2B, and (D) GluR1 in mouse forebrain. Protein data are averaged means of immunoreactive (IR) values relative to
total protein loads (mg). n = 5–9. Error bars represent SEM. * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0042327.g003
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Early onset of synaptic glutamate receptor concentration
is transient
To determine whether the precocious concentration of glutamate
receptor subunits in NR3A-KO mice is transient or sustained, we next
examined mice at P16 and P40–55, the period during and after which
synaptic refinements are completed, and when endogenous NR3A
levels are declining. Interestingly, we found no significant differences
between NR3A-KO and WT mice at P16 for NR1, NR2A, and
GluR1 protein levels (Figure 4, NR1% of control = 102.8611.6, n = 10,
p = 0.844; NR2A% of control = 119.5616.8, n = 10, p = 0.480;
GluR1% of control = 128.7617.1, n = 10, p = 0.201). Although
there appears to be a trend towards increased levels at
older ages, this effect did not achieve statistical significance. The
normalizationof the phenotype was maintained in more
mature mice (Figure 4, NR1% of control = 107.469.82, n = 9–10,
p = 0.601; NR2A% of control = 140.7620.4, n = 10, p = 0.123;
GluR1% of control = 124.8616.1, n = 10, p = 0.364), further confirming
that the premature concentration of synapse maturation markers,
NR1, NR2A, and GluR1 in the absence of NR3A is a transient effect.
Again, changes in NR2B levels were not detected (Figure 4,
NR2B% of P16 control = 113.3624.4, n = 9, p = 0.621 and
NR2B% of .P40 control = 87.1617.6, n = 7–10, p = 0.583). The
accelerated expression of NMDAR and AMPAR subunits in
immature NR3A-KO mice, along with the strong presence of
NR3A proteins in the developing but not adult rodent brain, support a
model in which NR3A negatively regulates glutamate receptor
expression during normal postnatal CNS development.
AMPAR-mediated currents are also transiently enhanced
and accelerated in NR3A-KO mice
In postnatal development, AMPARs are recruited to synapses
following LTP, resulting in the structural and functional maturation
of glutamatergic synapses [52,53,54,55]. Since NR3A-KO mice
demonstrate an early onset of hippocampal LTP [14] and GluR1 is
prematurely upregulated in PSD fractions, we next used direct
electrophysiological recordings to determine if functional AMPAR
responses were also prematurely enhanced through development.
To assay this, we recorded AMPAR currents from CA1 pyramidal
neurons in the hippocampus. We found that AMPAR-mediated
currents from P8 NR3A-KO mice displayed a two-fold increase in
the amplitudes of evoked EPSCs, compared to their WT controls
(Figure 5a). Similar to the biochemical results, the EPSC
amplitudes from NR3A-KOs were indistinguishable from controls
by P16 (Figure 5b). The early enhancement of AMPAR currents
at P8 is in agreement with the early onset of LTP in NR3A-KO
mice [14]. This indicates that the premature enhancements of both
AMPAR function and protein expression are transient in NR3A-
KO mice. Our observations thus support a model whereby NR3A
limits NMDAR functionality and, by limiting downstream
NMDAR signaling, NR3A-containing receptors reduce LTP-like
insertion of GluR1-containing AMPARs during early development.
Discussion
Inclusion of NR3A in NMDARs reduces currents, lowers
calcium permeability, and lowers the sensitivity of NMDARs to
Figure 4. Deletion of NR3A transiently accelerates expression of synapse maturation markers. (A) Representative immunoblots from
NR3A-KO compared to WT controls show increased PSD levels of (B) NR1, (C) NR2A, and (D) GluR1 at P8 that return to WT levels by P16 and adult
ages. (E) NR2B expression is unchanged in the NR3A-KO. (B, C, D, E) Data are averaged means of immunoreactive values relative to protein loads (mg)
and presented as percent of control values. NR1 values for age P8 are re-plotted here from [14] for comparative purposes. Error bars represent SEM.
n = 7–10. Significance from control: * p,0.05.
doi:10.1371/journal.pone.0042327.g004
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magnesium block. Given the importance of NR3A in shaping
NMDAR functions, it is surprising that relatively little is known
about the role of this subunit at the synapse. Therefore, we tested
the hypotheses that (1) NR3A-containing NMDARs shift from a
synaptic to a peri-/extrasynaptic location with development, and
(2) NR3A suppresses glutamate receptor activity during early life
to prevent premature synaptic strengthening and stabilization.
Our data show that NR3A is expressed at high levels and enriched
within the postsynaptic density (PSD) during early postnatal life
(P8). However, NR3A levels undergo a striking age-dependent
decline and are no longer enriched in the PSD fraction after P8.
Glutamate receptor subunit levels are increased in PSDs from
neonatal NR3A-KO mice, and this effect is normalized soon
afterward. This transient enhancement of NMDAR and AMPAR
expression is accompanied by accelerated functional AMPAR
responses that also return to WT levels in juvenile mice. These
results support the idea that NR3A-containing NMDARs restrict
the synaptic expression of NR1, NR2A, and GluR1. Because
concentration of these glutamate receptor subunits and the
development of AMPAR currents are key measures of synapse
maturation, our data indicate that the absence of NR3A results in
synapses that mature earlier than their WT counterparts. Such
changes might be expected if, in the narrow temporal window of
its highest expression, NR3A plays a regulatory role as a molecular
brake for the functional and structural changes associated with
synapse stabilization.
Our data suggest that NR3A levels not only decline with age,
but NR3A also undergoes redistribution from the PSD to other
biochemical compartments. In older animals, NR3A is relatively
more abundant in the SPM fraction (which includes TSF and
PSDs, Figure 2c: .P40) than in PSDs. This suggests that NR3A-
containing receptors in adults may be preferentially targeted
towards peri-/extrasynaptic sites. Such an age-dependent shift in
subcellular location would be consistent with mature hippocampal
culture data showing that NR3A-containing NMDARs have a
relatively uniform distribution at the membrane surface, reflecting
a weak association with the PSD [21]. In addition, a redistribution
of NR3A away from synaptic sites may further limit synaptic
activation of NR3A-containing NMDARs. Thus, NR3A-contain-
ing NMDARs on neurons may be rarely activated in adulthood,
and this may occur only under highly specialized circumstances
(such as periods of pronounced glutamate release and spillover).
We do not know whether increased synaptic localization of
NR1, NR2A, and GluR1 in week-old NR3A-KO mice could be
due to a change in transcription, translation, and/or a redistri-
bution of glutamate receptors. This question will take additional
experiments to answer, especially given that there is often
discrepancy between transcript and protein levels [56]. We are
intrigued by the possibility that the increased localization of NR1,
NR2A, and GluR1 could be due to redistribution of these proteins
into the PSD from non-synaptic pools. Glutamate receptors are
present at both perisynaptic and extrasynaptic sites, diffusing
laterally into the synapse under regulated conditions, presumably
through stabilization by MAGUK scaffolding proteins and
influenced by phosphorylation [57,58,59,60,61]. It is possible that
NR3A-containing receptors, through direct actions or through
interacting partners, may limit targeting of AMPARs and other
NMDAR subtypes to the PSD.
It is not yet known how NR3A-containing receptors might be
acting outside the PSD. Additional detailed ultrastructural
analyses of NR3A localization [33], as well as biochemical studies
that distinguish presynaptic and postsynaptic fractions [62], will
provide insight into how NR3A-containing NMDARs are
positioned to act outside the PSD. It is possible that the presence
or absence of NR3A affects presynaptic functions, given that
presynaptic NR3A-containing NMDARs have recently been
shown to modulate neurotransmitter release and spike timing-
dependent plasticity [33].
Intriguingly, NR3A directly suppresses NMDAR function
[8,12,14] and can limit AMPAR-mediated synaptic currents (ref.
Figure 5. Genetic deletion of NR3A accelerates the expression of AMPAR-mediated currents. (A) AMPA input-output (I–O) curve
demonstrating the amplitude of synaptic AMPAR currents recorded at 280 mV in CA1 pyramidal neurons from P8 NR3A-KO and WT controls (WT,
n = 12 neurons; NR3A-KO, n = 12 neurons). RMANOVA revealed a significant effect of genotype on AMPAR current amplitude across stimulation
intensities (F(1, 10) = 9.557, p = 0.005). (B) Synaptic AMPA currents recorded at P16–17 are similar between WT and NR3A-KO mice (WT, n = 13 neurons;
NR3A-KO, n = 11 neurons). In contrast to AMPA currents recorded at P8, there is no significant effect of genotype on synaptic AMPAR currents at this
age (RMANOVA, p = 0.99). Data are averaged means of NR3A-KO and control values. Error bars represent SEM. Significance from control: * p,0.05.
doi:10.1371/journal.pone.0042327.g005
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[14], and this study). Because each dendritic spine is thought to
contain a synapse [63,64], and NR3A-KO mice have higher spine
density [8], NR3A-KO mice would be expected to have more
functional synapses. One possibility is that LTP-like synaptic
enhancement in NR3A-KO mice might stabilize synapses, and
this could account for the enhanced excitatory synaptic transmis-
sion we observed in young KO mice. Although increased neonatal
AMPAR currents in NR3A-KO mice return to WT levels in
juvenile animals, it is interesting that increased spine densities in
NR3A-KOs remain elevated into adulthood [8]. Thus, the
synaptic removal of NR3A may increase AMPAR currents at
synapses, and this may help to stabilize synapses and lead to their
persistence.
Synapses in many CNS regions undergo significant remodeling
during postnatal brain development, although the molecules and
signaling pathways responsible for the elimination of inappropriate
synapses and the maintenance and strengthening of appropriate
connections are still largely unknown [65,66,67,68,69,70]. The
role of NMDARs in regulating these processes is debated. Recent
studies have separately proposed the ideas of NR2B and NR3A as
negative regulators of synapse stabilization [14,32], raising the
question of whether NMDAR subunit composition and/or
activation play a role. For example, because NMDAR assembly
and insertion into forebrain synapses is thought to rely on a
heteromeric combination of two NR1 subunits with NR3A and
one NR2 subunit, the acceleration of synapse maturation induced
by NR3A removal could be due to the selective loss of NR1/
NR2B/NR3A triheteromers. The loss of NR2B function resulting
in an increase in AMPAR-mediated mEPSC amplitudes [32]
might also occur through the loss of not only the NR1/NR2B
diheteromer, but also the NR1/NR2B/NR3A triheteromers,
meaning that the NR2B-deficient mouse would effectively ablate
both NR2B and NR3A expression.
NR3A expression at synapses is dependent on a number of
factors, including its unique intracellular interactions and associ-
ation with other NMDAR subunits. Unlike NR2 subunits [71,72],
PDZ binding sequences are conspicuously absent in NR3 subunits
[11,73]. Thus, the synaptic attachment of NR3A-NMDARs is
critically dependent upon NR2A and/or NR2B that can be
targeted to the PSD through PDZ-dependent interactions with
membrane-associated guanylate kinases (e.g., PSD-95 and
SAP102). Importantly, the synaptic removal of NR3A is an
activity-dependent process [21]. However, the effects that
MAGUK-NR2 interactions may have on the targeting, anchoring,
and stabilization of NR3A at synaptic sites are unknown. Future
experiments will be required to determine how the association
between synaptic glutamate receptors and PSD scaffolding
proteins changes during development. These will then provide
further clues as to how NR3A-NMDARs act as a molecular brake
by restricting the developmental onset of glutamate receptor
expression. One clue may come from a recent report showing that
a family of PDZ-binding domain proteins named takusans is
upregulated in NR3A-KO animals, resulting in altered expression
of AMPAR subunits to affect synaptic activity [74].
If NR3A is responsible for delaying the stabilization of
NMDARs and the insertion of AMPARs at the synapse, the
prolonged absence of NR3A would be expected to cause an
increase in the fraction of mature synapses. This idea is consistent
with the notion that activity-dependent NR3A removal by
PACSIN may ‘unsilence’ synapses through the insertion of more
mature NMDAR subtypes that trigger AMPAR insertion [14].
The early onsets of synaptic NMDAR currents and LTP in
NR3A-KO mice [14] are also in agreement with this interpreta-
tion, although these differences are not maintained in P16 and
adult mice. In this context, our data point to an as-yet-unidentified
signaling mechanism that links NMDAR inhibition to restricted
AMPAR trafficking. Alternatively, NR3A-containing receptors
may be actively involved in mediating developmental synapse
elimination. By limiting synapse potentiation, NR3A may affect
the fundamental measures of synapse maturation: synapse size,
synapse strength, and long-term memory.
Behavioral studies have only begun to address the long-term
implications of NR3A in the refinement of neural circuits capable
of learning and storing memories [14,75]. Resolving the temporal
and subcellular localization of NR3A protein, as we have done
here, is an important step toward this goal. Taken together with
recent data [14], our results contribute to a model whereby
inclusion of NR3A in NMDARs alters connections in the brain
anatomically, by influencing the number of dendritic spines, and
functionally, through weakened synaptic connections. NR3A
removal by PACSIN [21] would then relieve a developmental
brake on excitatory synapse stabilization, thus allowing/facilitating
the insertion of the more mature NMDAR subtype, NR2A, as well
as AMPARs.
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